TB-500 + BPC-157 Recovery Stack
Components: TB-500 + BPC-157
A 12-week recovery stack pairing TB-500 (5mg vial) and BPC-157 (5mg vial) with distinct dosing schedules. TB-500 dosed twice weekly loading then once weekly, BPC-157 dosed daily with titration.
Stack Components
This stack uses 2 separate vials — each peptide is reconstituted independently.
| Peptide | Dose | Frequency | Timing | Route |
|---|---|---|---|---|
| TB-500 Systemic cell migration and repair via actin regulation; promotes flexibility and anti-fibrotic healing | 1250 mcg | 2u00d7 per week (Weeks 1u20134); 1u00d7 per week (Weeks 5u201312) | Consistent days each week | SubQ |
| BPC-157 Local and systemic tissue repair, angiogenesis, anti-inflammation, growth factor upregulation | 250 mcg (Weeks 1u20132) u2192 500 mcg (Weeks 3u20138) u2192 250 mcg (Weeks 9u201312) | Once daily | Daily, consistent time | SubQ |
Reconstitution Guide
Each peptide in this stack is a separate vial. Reconstitute them one at a time using the parameters below.
TB-500
SubQBPC-157
SubQAlways use bacteriostatic water to reconstitute each vial. Draw from separate vials — do not mix in the same syringe unless your protocol specifies a shared injection.
Protocol Timeline
Full 12 weeks cycle breakdown.
TB-500: 1250 mcg (50 units) twice weekly. BPC-157: 250 mcg (10 units) once daily. TB-500 loading phase establishes systemic repair cell recruitment. BPC-157 starts low to assess tolerance.
TB-500: 1250 mcg twice weekly (loading continues). BPC-157: advance to 500 mcg once daily. Active repair phase u2014 expect progressive improvement in pain and mobility.
TB-500: reduce to 1250 mcg once weekly (maintenance phase). BPC-157: continue 500 mcg once daily. Tissue remodeling and consolidation of repair gains.
TB-500: continue 1250 mcg once weekly. BPC-157: reduce back to 250 mcg once daily. Gradual wind-down to allow assessment of healing progress. Consider a 4-week break before a second cycle if needed.
Synergy Notes
TB-500 provides systemic repair — it mobilizes repair cells from circulation through actin regulation and promotes flexibility and anti-fibrotic remodeling. BPC-157 anchors local healing through angiogenesis and growth factor signaling. The twice-weekly loading dose of TB-500 establishes systemic repair capacity, while daily BPC-157 ensures continuous local tissue support. The different schedules reflect their distinct half-lives and mechanisms.
What to Expect
Weeks 1–4: Initial pain reduction and improved local circulation. Weeks 5–8: Progressive mobility improvement and structural tissue repair. Weeks 9–12: Consolidation and assessment of healing extent. Most researchers report meaningful functional improvement by the end of week 6.
Questions about TB-500 + BPC-157 Recovery Stack
The twice-weekly loading phase in Weeks 1u20134 establishes higher systemic levels of TB-500 quickly, accelerating the mobilization of repair cells. After loading, the once-weekly maintenance dose sustains these levels with reduced injection frequency.
Subcutaneous injection near the injury site is a common research approach with BPC-157. Abdominal injection works systemically and avoids the need to inject near potentially painful areas.
Yes u2014 reconstitute each peptide in its own vial. Do not mix TB-500 and BPC-157 solutions together. Draw from each vial separately per injection schedule.
Research Use Disclaimer
This content is for educational purposes only and does not constitute medical advice. For research use only.